Prime-Boost Vaccination with SA-4-1BBL Costimulatory Molecule and Survivin Eradicates Lung Carcinoma in CD8+ T and NK Cell Dependent Manner
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference41 articles.
1. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion;RD Schreiber;Science,2011
2. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;PW Kantoff;N Engl J Med,2010
3. CD4+CD25+ T regulatory cells dominate multiple immune evasion mechanisms in early, but not late phases of tumor development in a B cell lymphoma model;KG Elpek;J Immunol,2007
4. Targeting CD4+CD25+FoxP3+ regulatory T-cells for the augmentation of cancer immunotherapy;RH Schabowsky;Curr Opin Investig Drugs,2007
5. 4-1BB ligand as an effective multifunctional immunomodulator and antigen delivery vehicle for the development of therapeutic cancer vaccines;RK Sharma;Cancer Res,2010
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-term antigen-specific immune response by an oncolytic adenovirus encoding SP-SA-E7-4-1BBL in HPV-16 cancer model;Molecular Biology Reports;2024-03-09
2. A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer;Cancer Immunology, Immunotherapy;2023-08-22
3. 4-1BBL as a Mediator of Cross-Talk between Innate, Adaptive, and Regulatory Immunity against Cancer;International Journal of Molecular Sciences;2021-06-09
4. The lytic activity of VSV-GP treatment dominates the therapeutic effects in a syngeneic model of lung cancer;British Journal of Cancer;2019-09-18
5. A Novel Form of 4-1BBL Prevents Cancer Development via Nonspecific Activation of CD4+ T and Natural Killer Cells;Cancer Research;2019-02-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3